Neogenomics's top three insider shareholders as of March 23, 2026 are Oort Douglas M Van (Director, 2.47Mn shares), Christopher M Smith (Chief Executive Officer, 641.59K shares), Mark Mallon (Chief Executive Officer, 368.05K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Oort Douglas M Van | 2,468,797 | 0 | 13 Aug, 2021 | |
| Christopher M Smith | Chief Executive Officer | 641,585 | 0 | 25 Feb, 2025 |
| Mark Mallon | Chief Executive Officer | 368,051 | 0 | 03 Mar, 2022 |
| George Cardoza | President Coo, Lab Ops | 244,157 | 0 | 03 Mar, 2022 |
| George Cardoza | President Coo, Lab Ops | 244,157 | 0 | 03 Mar, 2022 |
| Jeffrey Scott Sherman | Chief Financial Officer | 220,009 | 0 | 24 Feb, 2026 |
| William Bonello | Chief Financial Officer | 191,548 | 0 | 02 May, 2022 |
| Douglas Matthew Brown | Chief Strategy Officer | 158,684 | 0 | 04 Apr, 2022 |
| Robert J. Shovlin | President, Clinical Services | 150,101 | 0 | 27 May, 2021 |
| Warren Stone | Pres Chief Operating Officer | 147,714 | 0 | 24 Feb, 2026 |
| Halley E Gilbert | Chief Legal Officer | 147,396 | 0 | 03 Mar, 2022 |
| Alison L. Hannah | 131,023 | 0 | 03 Jun, 2025 | |
| Lawrence Martin Weiss | Chief Medical Officer | 130,847 | 0 | 26 Apr, 2021 |
| Vishal Sikri | President Advanced Diagnostics | 127,716 | 0 | 02 Jun, 2023 |
| Melody Harris | Chf Ops Off, Pres, Informatics | 109,755 | 0 | 25 Feb, 2025 |
| Alicia C Olivo | Evp, Gc Business Development | 93,224 | 0 | 24 Feb, 2026 |
| Shashikant Kulkarni | Chief Scientific Officer | 82,673 | 0 | 04 Apr, 2023 |
| Lynn A. Tetrault | 73,652 | 0 | 03 Jun, 2025 | |
| Bruce K Crowther | 65,120 | 0 | 14 Jun, 2022 | |
| Stephen M Kanovsky | 52,344 | 0 | 03 Jun, 2025 | |
| Kathryn B Mckenzie | Chief Sustainability/Risk Ofcr | 49,361 | 0 | 12 Jan, 2022 |
| Jennifer Balliet | Vp And Chief Culture Officer | 48,615 | 0 | 30 Dec, 2021 |
| Michael Aaron Kelly | 44,009 | 0 | 03 Jun, 2025 | |
| David Sholehvar | President, Clinical Services | 43,216 | 0 | 03 Aug, 2022 |
| Clive Morris | President Of Inivata | 41,280 | 0 | 30 Dec, 2021 |
| Anthony P. Zook | Chief Executive Officer | 38,066 | 0 | 06 Aug, 2025 |
| Kevin C Johnson | 37,398 | 0 | 23 Dec, 2021 | |
| David Brian Perez | 33,890 | 0 | 03 Jun, 2025 | |
| Gina M Wallar | President, Pharma Services | 33,443 | 0 | 03 Mar, 2022 |
| Cynthia J Dieter | Chief Accounting Officer | 29,765 | 0 | 03 Mar, 2023 |
| Neil Gunn | 28,100 | 0 | 03 Jun, 2025 | |
| Elizabeth Floegel | 23,590 | 0 | 03 Jun, 2025 | |
| Greg D Aunan | Chief Accounting Officer | 22,027 | 0 | 24 Feb, 2026 |
| Rachel A Stahler | 21,335 | 0 | 14 Jun, 2022 | |
| Anthony P. Zook | Chief Executive Officer | 0 | 18,900 | 08 May, 2025 |
| David Daly | 17,179 | 0 | 14 Jun, 2022 | |
| David Brian Perez | 0 | 10,000 | 07 May, 2025 | |
| Felicia Williams | 7,160 | 0 | 03 Jun, 2025 | |
| Lynn A. Tetrault | 0 | 7,000 | 13 May, 2025 | |
| Michael Aaron Kelly | 0 | 5,000 | 28 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Mar, 2026 | Warren Stone | Stock Option (Right to Buy) | A | 253,378 | $0.00 | 253,378 | D | A |
| 01 Mar, 2026 | Greg D Aunan | Stock Option (Right to Buy) | A | 36,825 | $0.00 | 36,825 | D | A |
| 01 Mar, 2026 | Alicia C Olivo | Stock Option (Right to Buy) | A | 147,804 | $0.00 | 147,804 | D | A |
| 01 Mar, 2026 | Warren Stone | Restricted Stock Unit | A | 152,594 | $0.00 | 152,594 | D | A |
| 01 Mar, 2026 | Anthony P. Zook | Stock Option (Right to Buy) | A | 675,676 | $0.00 | 675,676 | D | A |
| 01 Mar, 2026 | Greg D Aunan | Restricted Stock Unit | A | 22,889 | $0.00 | 22,889 | D | A |
| 01 Mar, 2026 | Alicia C Olivo | Restricted Stock Unit | A | 89,013 | $0.00 | 89,013 | D | A |
| 01 Mar, 2026 | Anthony P. Zook | Restricted Stock Unit | A | 406,918 | $0.00 | 406,918 | D | A |
| 21 Feb, 2026 | Alicia C Olivo | Common Stock | A | 21,079 | $0.00 | 96,399 | D | M |
| 21 Feb, 2026 | Jeffrey Scott Sherman | Common Stock | A | 42,158 | $0.00 | 218,986 | D | M |
| 21 Feb, 2026 | Greg D Aunan | Common Stock | A | 6,323 | $0.00 | 23,902 | D | M |
| 21 Feb, 2026 | Warren Stone | Common Stock | A | 28,105 | $0.00 | 149,736 | D | M |
| 21 Feb, 2026 | Jeffrey Scott Sherman | Common Stock | D | 10,729 | $0.00 | 208,257 | D | F |
| 21 Feb, 2026 | Warren Stone | Common Stock | D | 7,142 | $0.00 | 142,594 | D | F |
| 21 Feb, 2026 | Greg D Aunan | Common Stock | D | 1,875 | $0.00 | 22,027 | D | F |
| 21 Feb, 2026 | Alicia C Olivo | Common Stock | D | 8,295 | $0.00 | 88,104 | D | F |
| 23 Feb, 2026 | Alicia C Olivo | Common Stock | A | 8,443 | $0.00 | 96,547 | D | M |
| 23 Feb, 2026 | Warren Stone | Common Stock | A | 8,443 | $0.00 | 151,037 | D | M |
| 23 Feb, 2026 | Jeffrey Scott Sherman | Common Stock | A | 15,535 | $0.00 | 223,792 | D | M |
| 21 Feb, 2026 | Greg D Aunan | Restricted Stock Unit | D | 6,323 | $0.00 | 12,648 | D | M |